Rubric Capital Management LP Mereo Biopharma Group PLC Transaction History
Rubric Capital Management LP
- $3.49 Billion
- Q1 2025
A detailed history of Rubric Capital Management LP transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Rubric Capital Management LP holds 15,307,347 shares of MREO stock, worth $41.3 Million. This represents 0.99% of its overall portfolio holdings.
Number of Shares
15,307,347
Previous 15,307,347
-0.0%
Holding current value
$41.3 Million
Previous $53.6 Million
35.71%
% of portfolio
0.99%
Previous 0.89%
Shares
11 transactions
Others Institutions Holding MREO
# of Institutions
100Shares Held
112MCall Options Held
1MPut Options Held
668K-
Janus Henderson Group PLC London, X022.7MShares$61.4 Million0.03% of portfolio
-
Mangrove Partners New York, NY8.64MShares$23.3 Million3.05% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA7.82MShares$21.1 Million1.11% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY6.71MShares$18.1 Million0.38% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD6.68MShares$18 Million0.9% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $337M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...